Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 31908 [2015-13623]
Download as PDF
31908
Federal Register / Vol. 80, No. 107 / Thursday, June 4, 2015 / Notices
and Ordering Information Clause, in all
correspondence.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: May 29, 2015.
Jeffrey A. Koses
Director, Office of Acquisition Policy. Office
of Government-wide Policy.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–13703 Filed 6–3–15; 8:45 am]
[FR Doc. 2015–13623 Filed 6–3–15; 8:45 am]
[FR Doc. 2015–13621 Filed 6–3–15; 8:45 am]
BILLING CODE 6820–61–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced in
this notice concerns Natural
Experiments of the Impact of
Population-targeted Health Policies to
Prevent Diabetes and its Complications,
DP15–001, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
DATES: 11 a.m.–3 p.m., June 23, 2015
(Closed).
ADDRESSES: Teleconference.
FOR FURTHER INFORMATION CONTACT:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway, NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:(770)
488–6295, BJC4@cdc.gov.
SUPPLEMENTARY INFORMATION:
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Natural Experiments of the Impact of
Population-targeted Health Policies to
Prevent Diabetes and its Complications,
DP15–001, initial review’’. This meeting
is being held to review one application
that was not reviewed in the initial
meeting on May 5–6, 2015.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
wreier-aviles on DSK5TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:33 Jun 03, 2015
Jkt 235001
In accordance with Section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC) announces a meeting
for the initial review of applications in
response to Funding Opportunity
Announcement (FOA), RFA–EH–15–
001, Environmental Health Specialists
Network (EH-Net)—Practice based
research to improve food safety.
SUMMARY:
10 a.m.–5 p.m., EDT, July 2, 2015
(Closed).
DATES:
ADDRESSES:
Teleconference.
M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Hwy. NE.,
Mailstop E63, Atlanta, Georgia 30341–
3724, Telephone: 770–488–4334.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Environmental Health Specialists
Network (EH-Net)—Practice based
research to improve food safety’’, EH15–
001.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section
10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463), the
Centers for Disease Control and
Prevention (CDC) announces a meeting
for the initial review of applications in
response to Funding Opportunity
Announcement (FOA), RFA–CE–15–
002, The CDC National Center for
Excellence in Youth Violence
Prevention: Building the Evidence for
Community- and Policy-Level
Prevention.
DATES: 8:30 a.m.–5 p.m., EDT, June 29–
30, 2015 (Closed).
ADDRESSES: The Georgian Terrace, 659
Peachtree Street NE., Atlanta, Georgia
30308. This meeting will also be held by
teleconference.
FOR FURTHER INFORMATION CONTACT: M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Hwy. NE.,
Mailstop E63, Atlanta, Georgia 30341–
3724, Telephone: 770–488–4334.
SUPPLEMENTARY INFORMATION:
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘The CDC National Center for
Excellence in Youth Violence
Prevention: Building the Evidence for
Community- and Policy-Level
Prevention’’ FOA Number: CE–15–002.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
SUMMARY:
E:\FR\FM\04JNN1.SGM
04JNN1
Agencies
[Federal Register Volume 80, Number 107 (Thursday, June 4, 2015)]
[Notices]
[Page 31908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-13623]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
SUMMARY: The meeting announced in this notice concerns Natural
Experiments of the Impact of Population-targeted Health Policies to
Prevent Diabetes and its Complications, DP15-001, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting:
DATES: 11 a.m.-3 p.m., June 23, 2015 (Closed).
ADDRESSES: Teleconference.
FOR FURTHER INFORMATION CONTACT: Brenda Colley Gilbert, Ph.D.,
M.S.P.H., Director, Extramural Research Program Operations and
Services, CDC, 4770 Buford Highway, NE., Mailstop F-80, Atlanta,
Georgia 30341, Telephone:(770) 488-6295, BJC4@cdc.gov.
SUPPLEMENTARY INFORMATION:
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Natural Experiments of the Impact of Population-targeted Health
Policies to Prevent Diabetes and its Complications, DP15-001, initial
review''. This meeting is being held to review one application that was
not reviewed in the initial meeting on May 5-6, 2015.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2015-13623 Filed 6-3-15; 8:45 am]
BILLING CODE 4163-18-P